Navin Fluorine International LimitedQ1 FY27 Results & Financial Update

Total HF capacity across Surat and Dahej stands at 60,000 tons, which management views as sufficient for the next four to five years.

The INR 90 crore advanced materials adoption capex is designed to self-earn by commercializing already lab-approved products, minimizing upfront capital risk.

India capacity additions for R32 will target global export markets as global demand is projected to double while quota-driven supplies shrink over the decade.

Management noted increasing customer interest in contractually committing for R32 supplies over the next five years, targeting 35% to 45% of total capacity under long-term contract while retaining an open market position.

Strong visibility for campaign orders across at least four to five molecules in the agchem space this year, out of which three are patented molecules avoiding standard pricing pressure.

Additional R32 HFC capacity equivalent to up to 15,000 metric tons remains on track for commissioning in Q3 FY27, alongside debottlenecking at Dahej MPP facilities.

The INR 90 crore adoption capacity capex at Surat is being executed in phases, with the first phase completing by the middle of Q4 FY28 to enable commercial-scale customer qualifications for roughly five lab-approved products.

An investment of INR 15.73 crores in a group captive hybrid renewable project (14.9 MW) is expected to meet over 60% of power requirements once operational.

Management expects operating EBITDA margins to normalize around a range of 32% to 33% (plus/minus 1%) supported by operating leverage from upcoming HFC, debottlenecking, and Chemours capacities.

Integration of the HF value chain and upcoming renewable power savings are targeted to sustain low-cost manufacturing advantages for R32 across cycles.

Navin Fluorine achieved a net debt-free status during Q1 FY27, backed by Q1 operating cash flows of INR 173 crores.

Management reaffirmed that the CDMO business target of $100 million in revenue remains firmly on track.

Reiterated an expected asset turn of 3x on the INR 288 crores cGMP4 capex by FY29 or potentially sooner.

Management clarified that advanced materials focus on high-growth sectors (data centers, electronics, semiconductor fabrication, OLED displays, chip cooling, and fire suppressants) and will act as a combination of product and service plays.

Management emphasized that despite domestic capacity additions, R32 should be viewed in a global context where Chinese quotas are tightening and Navin's low-cost integrated manufacturing protects group EBITDA.

Management confirmed that Phase 2 cGMP4 capacity is dedicated to an existing European partner, extending participation to API minus 1 via an MSA for an additional molecule.

Management confirmed Navin is the exclusive supplier to Chemours for the 2-phase cooling liquid project, with the 15-month ramp-up window remaining valid post-Q2 FY27 commissioning.

Management explained that gross margins experienced a mild sequential pullback due to rising raw material costs from geopolitical supply chain tensions, but fixed-cost efficiencies and productivity gains preserved EBITDA margin levels.